Cargando…

A New Tool for CRISPR-Cas13a-BasedCancer Gene Therapy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Gao, Jinliang, Luo, Tao, Lin, Na, Zhang, Shuyan, Wang, Jinke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591403/ https://www.ncbi.nlm.nih.gov/pubmed/34820506 http://dx.doi.org/10.1016/j.omto.2021.10.007

Ejemplares similares

A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy
por: Gao, Jinliang, et al.
Publicado: (2020)

Correction to: CRISPR/Cas: a potential gene-editing tool in the nervous system
por: Gao, Yanxia, et al.
Publicado: (2021)

Gene interfered-ferroptosis therapy for cancers
por: Gao, Jinliang, et al.
Publicado: (2021)

Correction: CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool
por: Stemmer, Manuel, et al.
Publicado: (2017)

CRISPR-Cas: ‘The Multipurpose Molecular Tool’ for Gene Therapy and Diagnosis
por: Sauvagère, Stéphane, et al.
Publicado: (2023)

Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapy
por: Biagioni, Alessio, et al.
Publicado: (2019)

Gene activation by a CRISPR-assisted trans enhancer
por: Xu, Xinhui, et al.
Publicado: (2019)

CRISPR/Cas: a potential gene-editing tool in the nervous system
por: Gao, Yanxia, et al.
Publicado: (2020)

CRISPR-Cas13a system: A novel tool for molecular diagnostics
por: Zhao, Lixin, et al.
Publicado: (2022)

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Targeted gene silencing in the nervous system with CRISPR-Cas13
por: Powell, Jackson E., et al.
Publicado: (2022)

Effects of Two Kinds of Iron Nanoparticles as Reactive Oxygen Species Inducer and Scavenger on the Transcriptomic Profiles of Two Human Leukemia Cells with Different Stemness
por: Luo, Tao, et al.
Publicado: (2020)

Author Correction: CRISPR-Cas12a-assisted nucleic acid detection
por: Li, Shi-Yuan, et al.
Publicado: (2019)

Metagenomic discovery of novel CRISPR-Cas13 systems
por: Hu, Yanping, et al.
Publicado: (2022)

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs
por: Crippa, Stefania, et al.
Publicado: (2022)

Author Correction: Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria
por: Dong, Chen, et al.
Publicado: (2018)

Generate TALE/TALEN as Easily and Rapidly as Generating CRISPR
por: Zhang, Shuyan, et al.
Publicado: (2019)

Inflammation conditional genome editing mediated by the CRISPR-Cas9 system
por: Yuan, Tingting, et al.
Publicado: (2023)

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

CRISPR-typing PCR (ctPCR), a new Cas9-based DNA detection method
por: Wang, Qiao, et al.
Publicado: (2018)

Correction to: Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Correction to ‘Improving CRISPR–Cas specificity with chemical modifications in single-guide RNAs’
Publicado: (2022)

Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing
por: Zhang, Xin, et al.
Publicado: (2023)

Correction to: Rescue of premature aging defects in Cockayne syndrome stem cells by CRISPR/Cas9-mediated gene correction
por: Wang, Si, et al.
Publicado: (2022)

CaSilico: A versatile CRISPR package for in silico CRISPR RNA designing for Cas12, Cas13, and Cas14
por: Asadbeigi, Adnan, et al.
Publicado: (2022)

Author Correction: Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells
por: Chen, Yuxi, et al.
Publicado: (2020)

CRISPR/Cas13d-Mediated Microbial RNA Knockdown
por: Zhang, Kun, et al.
Publicado: (2020)

CRISPR-Cas13: A new technology for the rapid detection of pathogenic microorganisms
por: Huang, Zhanchao, et al.
Publicado: (2022)

Structural basis for the activation of a compact CRISPR-Cas13 nuclease
por: Deng, Xiangyu, et al.
Publicado: (2023)

Correction: Profiling the impact of the promoters on CRISPR-Cas12a system in human cells
por: Li, Jinhe, et al.
Publicado: (2023)

Development and Application of CRISPR-Cas Based Tools
por: Hu, Yanping, et al.
Publicado: (2022)

Diagnostics of Infections Produced by the Plant Viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13
por: Marqués, María-Carmen, et al.
Publicado: (2022)

Carrier strategies boost the application of CRISPR/Cas system in gene therapy
por: Xu, Zunkai, et al.
Publicado: (2022)

Amplification-free RNA detection with CRISPR–Cas13
por: Shinoda, Hajime, et al.
Publicado: (2021)

Correction to ‘Activating cryptic biosynthetic gene cluster through a CRISPR–Cas12a-mediated direct cloning approach’
Publicado: (2022)

Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13
por: Wang, Hao, et al.
Publicado: (2022)

CRISPR/Cas systems: Delivery and application in gene therapy
por: Huang, Jie, et al.
Publicado: (2022)

Programmable CRISPR interference for gene silencing using Cas13a in mosquitoes
por: Kulkarni, Aditi, et al.
Publicado: (2020)

CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification
por: Quansah, Elvis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uv3v3nvag1o79sgsggib8l81u7